T[he]{.smallcaps}nucleus in the yeast *Saccharomyces cerevisiae* migrates to distinct regions within the cell during different phases of the life cycle, mating, and mitosis. Each type of nuclear migration is dependent upon cytoplasmic microtubules. The cytoplasmic microtubules are attached to the nucleus at the spindle pole body (SPB),^1^ the microtubule organizing center in yeast. The SPB is embedded in the nuclear envelope, which remains intact at all stages of the yeast life cycle ([@B4]).

In preparation for mating, the yeast cell arrests in G1 and forms a projection---called a shmoo projection---in response to mating pheromone. The nucleus moves to the base of the shmoo neck and the cytoplasmic microtubules extend from the SPB to the tip of the shmoo ([@B5]; [@B43]; [@B38]). Two shmoos of opposite mating type fuse to form a zygote and the intervening cell walls break down ([@B6]). The cytoplasmic microtubules can then interdigitate, and the nuclei are drawn together in a microtubule-dependent manner by the Kar3p kinesin-like motor protein. Karyogamy, or nuclear fusion, then ensues ([@B30]). The process of nuclear and cell fusion has recently been reviewed ([@B42]; [@B28]).

Nuclear migrations also occur during mitotic divisions in yeast. At the end of G2 phase the nucleus moves up to the neck, between the mother and bud ([@B37]). The nucleus then elongates quickly, coincident with ([@B54]), or just before ([@B20]) translocation of the sausage-shaped nucleus into the neck. The sausage-shaped nucleus then undergoes a rapid set of oscillations across the bud neck ([@B54]). The function of these oscillations remains unknown, but may correspond to the "DNA transits" observed by others ([@B33]). The nucleus then undergoes a slower phase of elongation. It takes on an hour-glass shape until the two lobes of the nucleus are located at the distal poles of the mother and bud. After a brief pause, each of the nuclei returns to the center of its respective cell. Cytokinesis then follows ([@B54]). In cells undergoing axial budding, the nucleus then reorients such that the SPB faces the site of new bud emergence ([@B6]; [@B47]).

The cytoplasmic microtubules are required for most, if not all, nuclear migrations ([@B48]). Specific depolymerization of the cytoplasmic microtubules using a cold-sensitive allele of β-tubulin, *TUB2-401*, results in a massive failure of nuclear migration. The nuclear division cycle as well as the budding cycle continue in the absence of nuclear migration into the growing bud. This results in a multinucleated mother cell surrounded by a rosette of anucleate buds ([@B48]).

Another gene that plays a critical role in nuclear migration is the minus end--directed microtubule motor protein, cytoplasmic dynein, *DHC1*/*DYN1* ([@B23]; [@B12]). Deletion of dynein from the yeast cell results in the failure of the nucleus to fully migrate to the bud neck, with spindle elongation occurring entirely within the mother cell ([@B23]). Interestingly, the nuclear oscillations that occur in the neck of wild-type cells are absent in dynein mutant strains. One model for dynein function in yeast is that it exerts a pulling force on the cytoplasmic microtubules, perhaps through an attachment to the cell surface ([@B23]; [@B12]). Indeed, such a cortical localization is found for cytoplasmic dynein in the filamentous fungus, *Aspergillus nidulans* ([@B52]).

Several other genes have been implicated in the process of nuclear migration, including *ACT5* and *JNM1.* Whereas neither gene is essential, both mutants have nuclear migration phenotypes strikingly similar to that of dynein heavy chain mutants ([@B7]; [@B29]; [@B31]). *ACT5* is the yeast homologue of the Arp1 component of the vertebrate dynactin complex ([@B7]; [@B31]). Jnm1p has also been suggested to be an auxiliary subunit for cytoplasmic dynein ([@B29]; [@B15]). Consistent with this hypothesis, the double mutant, *dhc1 act5*, is not significantly worse for nuclear migration than either single mutant alone ([@B31]). These data indicate that Dhc1p and Act5p function in the same pathway to promote nuclear migration ([@B31]). Another protein, Num1p, also affects nuclear migration, possibly affecting cytoplasmic microtubule functions. It localizes primarily to the mother cell cortex and is expressed in a cell cycle--dependent manner (Farkasovsky and Kuntzel, 1995).

Nuclear migration has been extensively characterized in the filamentous fungi *Aspergillus nidulans* and *Neurospora crassa.* Nuclei migrate down the germ tube of these filamentous fungi before hyphal segmentation. As in *Saccharomyces cerevisiae*, the nuclear movements require microtubules, cytoplasmic dynein, and dynactin components ([@B36]; [@B52]). Three other *Aspergillus* genes have also been identified that are also required for nuclear migration: *nudG* ([@B50]); *nudF* ([@B51] *a*), a gene with homology to the human *LIS-1* gene; and *nudC* ([@B32]), which controls the level of the NUDF protein.

In *S. cerevisiae*, [@B22] have shown that in *kar9* mutant zygotes the cytoplasmic microtubules are misoriented and that the nuclei fail to migrate together. Thus the two haploid nuclei in *kar9* zygotes remain widely separated ([@B22]). In this paper, we investigated the function of Kar9p during the mitotic and early mating stages of the yeast life cycle. In both instances, we found nuclear migration and microtubule orientation defects in *kar9.* Genetic interactions between *KAR9* and *DHC1*/*DYN1* mutations indicated that *KAR9* functions in a nuclear migration pathway that is at least partially redundant with the dynein pathway. A fusion of green fluorescent protein (GFP) to Kar9p localized to a cortical region at the tip of the bud and at the tip of the shmoo projection in a microtubule-independent fashion. We propose that Kar9p functions as a cytoplasmic tether or adaptor linking the cytoplasmic microtubules to a specific site at the bud cortex.

Materials and Methods {#MaterialsMethods}
=====================

Strains and Cell Culture
------------------------

The yeast strains used in this study are listed in Table [I](#TI){ref-type="table"}. Bacterial strains and plasmids are listed in Table [II](#TII){ref-type="table"}. Yeast cells were cultured by standard methods as described previously ([@B45]). To prepare shmoos, cells were arrested with α factor (Syn/Seq facility; Princeton University, Princeton, NJ) at 10 μg/ml for 90 or 180 min in yeast peptone dextrose (YPD) media. The longer arrest time was used when induction of GFP-Kar9p was also required.

Fluorescence and Immunological Techniques
-----------------------------------------

Morphological analysis of cells and shmoos by 4′,6-diamidino-2-phenylindole (DAPI) staining was performed as described ([@B45]). For nuclear migration analyses (see below), cells and shmoos were fixed with methanol/acetic acid (3:1) on ice for 30 min, washed twice in PBS, and then stained with DAPI (1 μg/ml). Indirect immunofluorescence of microtubules was performed as described ([@B45]). Cytoplasmic microtubules were stained with rabbit anti--β tubulin (a gift from F. Solomon, Massachusetts Institute of Technology, Cambridge, MA) at 1:500 dilution or rat anti--α tubulin YOL 1/34 neat (Accurate Biochemical, Westbury, NY). Double-label immunofluorescence was carried out with rabbit anti-GFP (CLONTECH, Palo Alto, CA) at a dilution of 1:30 and goat anti--rabbit conjugated with FITC (Boehringer Mannheim, Indianapolis, IN) at a 1:55 dilution. Each antibody was applied serially to the cells for 24 h at 4°C in the following order: anti-GFP, anti-tubulin YOL1/34, and mixed secondaries of goat anti-rabbit--FITC and goat anti--rat conjugated with Texas red (Organon Teknika Corp., West Chester, PA). Both anti-GFP and its secondary antibody were preabsorbed against a formaldehyde-fixed, zymolyase-digested wild-type strain lacking the *GFP-KAR9* plasmid. Microscopy was done on an Axiophot microscope equipped with a ×100 Neofluor lens (1.4NA) (Carl Zeiss, Inc., Thornwood, NY).

Isolation and Genetic Mapping of the KAR9 Gene
----------------------------------------------

The wild-type *KAR9* gene was cloned using a yeast genomic centromere-based library ([@B44]). 100,000 transformants were screened for suppression of *kar9-485\'*s benomyl sensitivity using plates containing 20 μg/ml of benomyl incubated at 30°C. The plasmids that complemented were recovered from yeast using the procedure of [@B16] and retransformed into *Escherichia coli.* Candidate plasmids were mapped by restriction enzyme digest analysis. Three independently isolated plasmids were found to overlap by 5.8 kb. These plasmids were retested to determine whether they suppressed both the benomyl sensitivity and the mitotic defects of *kar9-485.* An internal 1.4-kD SpeI-SpeI fragment in the overlap region was used to carry out physical mapping. Pulse field gel electrophoresis and Southern blots were carried out by the methods of [@B45], and graciously provided by L.J. Kurihara (Princeton University, Princeton, NJ). λ prime clone blots were used by the methods of [@B39].

Sequencing
----------

Subclones used for complementation analysis (see Fig. [1](#F1){ref-type="fig"}) and several ExoIII nuclease deletion constructs (data not shown) were sequenced using the Sequenase Version 2.0 kit (United States Biochemical Corp., Cleveland, Ohio), and double-stranded templates. This sequence was verified by the *S. cerevisiae* genome project. *KAR9* corresponds to open reading frame (ORF) No. YPL269W on chromosome XVI. Analysis of the DNA sequence was carried out using the GCG program (Wisconsin software package; Oxford Molecular Group, Inc., Oxford, UK). Analysis of potential coiled-coils regions was by the Coils program ([@B26]).

Linkage Analysis
----------------

To construct an integration vector for use in linkage analysis, we cloned the 2.1-kb SpeI-SpeI fragment of this region into a *URA3*-containing integration vector pRS406 to create pMR2886 (see Fig. [1](#F1){ref-type="fig"}). This was cleaved with BglII, and integrated into the wild-type diploid, MS810, thus marking the wild-type *KAR9* locus with *URA3.* After sporulation, a colony with the *URA3*-marked *KAR9* locus was mated to a *kar9-485* strain (MS3662), sporulated, and then tetrads were dissected. Of 32 tetrads analyzed, the *URA3*-marked wild-type *KAR9* locus segregated together with benomyl resistance in 31 tetrads. The remaining tetrad segregated 2:2 for benomyl resistance, but contained three Ura− spores, two of which were benomyl sensitive, and one of which was benomyl resistant. The Ura− benomyl-resistant spore most likely represents a gene conversion event or a plasmid loop-out event leading to loss of the *URA3* plasmid.

Construction of the KAR9 Deletion Strains
-----------------------------------------

Two null alleles of *KAR9* were constructed (see Fig. [1](#F1){ref-type="fig"}). For *kar9-Δ1:: LEU2*, amino acids 7--644 were deleted and replaced with *LEU2.* This nearly complete deletion of *KAR9* was constructed by cutting the *KAR9*-containing plasmid, MS3381, with BglII and SpeI, and then replacing the deleted *KAR9* fragment with an XbaI/BamHI fragment containing the *LEU2* gene from the YIp vector, pMR2254. This yielded the *kar9-Δ1:: LEU2* deletion plasmid, pMR3382. *kar9-2Δ::HIS3*, which replaces amino acids 7--574, was constructed by cutting pMR3381 with BglII and BamHI and replacing it with a BamHI/BamHI fragment containing the *HIS3* gene from B886 (from J. Broach, Princeton University). This created the *kar9-Δ2::HIS3* disruption plasmid, pMR3386. Both the *kar9-Δ1::LEU2* and the *kar9-Δ2::HIS3* deletion mutations were introduced into the genomic locus of the haploid strains by the one-step gene replacement method of [@B46]. A 2.6-kb fragment liberated by SwaI digestion of pMR3382 and pMR3386 was gel purified and transformed into the wild-type strains, MS52 and MS1556, to create strains MS4062, MS4263, and MS4306. Whereas both deletions leave the NH~2~-terminal six amino acids of Kar9p intact, this small fragment is unlikely to be functionally significant. The *kar9-Δ1::LEU2* and *kar9-Δ2::HIS3* deletions were confirmed by Southern blot analysis and diagnostic PCR analysis, respectively. Both the *kar9-Δ1:: LEU2* and the *kar9-Δ2::HIS3* mutations in yeast result in benomyl sensitivity and mitotic defects identical to those described for the original point mutant, *kar9-485.* There was no difference in the growth rate between *kar9Δ* and wild-type strains.

Construction of Mutants
-----------------------

### dhc1Δ.

The *dhc1Δ::URA* disruption ([@B23]) was made in an isogenic strain background by the one-step gene replacement method ([@B46]). The plasmid pBR2-1U ([@B23]) was cleaved with EcoRI, the 2.2-kb fragment was gel purified, and transformed into the wild-type strain, MS52, to create MS4262. Consistent with the creation of the proper disruption, the *dhc1Δ::URA* segregated 2:2 in crosses to wild type. The *dhc1Δ::URA* disruption strain was benomyl sensitive (20 μg/ml at 30°C), and also exhibited the same array of mitotic spindle orientation defects as expected from previous reports ([@B12]; [@B23]).

### jnm1Δ.

The *jnm1Δ* disruption was made in a strain isogenic with *kar9Δ* by the one-step gene replacement method ([@B46]). pJM1432 ([@B29]) was digested with XbaI and the 4.8-kb fragment was gel purified. Transformation of this fragment into MS1556 produced the *jnm1* deletion strain, MS4321.

### act5Δ.

The *act5Δ::HIS3* disruption strain, YJC1159 ([@B31]), was back-crossed to MS1556 yielding the *act5Δ* strain, MS4586.

### bik1Δ.

pVB17 was digested with SnaBI and EcoRI to liberate a 3.3-kb fragment. This was transformed into MS52 to create the *bik1::TRP1* strain, MS4734, by the one-step gene replacement method.

Construction of GFP-KAR9
------------------------

To construct a GFP-Kar9p fusion protein, the *KAR9* gene was synthesized with SalI ends by PCR using the following primers:

*KAR9*-NH~2~ 5′-AC GCG TCG ACC ATG GAT AAT GAT GG-3′ and

*KAR9*-COOH 5′-GCG TGT CGA CTC AAT AAG TTG GGG-3′.

The resulting PCR product was cleaved with SalI and cloned in frame at the SalI site of the centromere based P*~GAL1~*-GFP vector, B1893, to create the P*~GAL1~*-*GFP--KAR9* construct, pMR3465. The centromere based P*~GAL1~*-GFP--cloning vector, B1893, was constructed by C. Davis (Princeton University) by combining the No. 1 GFP mutant of B. Cormack and S. Falkow (Cormack, 1996) and the YCpIF1 vector of Foreman and Davis ([@B14]).

Cell Culture, Fixation Methods and Drug Treatments of GFP-Kar9p--expressing Strains
-----------------------------------------------------------------------------------

For induction of GFP-Kar9p by galactose, cells were grown to early exponential phase in synthetic complete minus leucine media containing 2% raffinose, 2% galactose, and either no glucose or 0.1% glucose. Growth curve analysis demonstrated that induction of *GFP-KAR9* by addition of 2% galactose did not inhibit growth in *kar9Δ* strains (MS4306) or wild-type strains (MS1556) for as long as 10 h of induction. However, to produce lower expression levels more like that found in wild type, 0.1% glucose was added to the culture media. This resulted in the reduction of GFP-Kar9p expression levels by approximately fivefold as determined by Western blot analysis.

For GFP-Kar9p localization studies, the following conditions were used. For vegetatively growing cells the wild-type strain containing a GFP-Kar9p plasmid, MS4387, was grown to early exponential phase in synthetic complete minus leucine media containing 2% raffinose, 2% galactose, and 0.1% glucose. To visualize the nuclear material in these cells, cells were fixed in 3.7% formaldehyde for 5--10 min, washed three times in PBS, and stained with DAPI (1 μg/ml). For shmoos the *kar9* delete stain, MS4382, was grown to early exponential phase in synthetic complete minus leucine media containing 2% raffinose. GFP-Kar9p expression was induced for 4 h with 2% galactose. After 1--2.5 h, α factor (10 μg/ml) was added to arrest the cells for 1.5--3 h. For zygotes, **a** and α wild-type cells were grown to early log phase in synthetic complete minus leucine media containing 2% raffinose (MS4387 and MS4671). Cells were induced for GFP-Kar9p expression for 2.5--3 h by the addition of galactose (2%), and then allowed to mate on YPD for 2--3 h. Shmoos and zygotes were fixed with 3.7% formaldehyde for 1 h, lightly spheroplasted with glusulase NEE-154 (DuPont-NEN, Boston, MA) and stained with DAPI (1 μg/ml).

For nocodazole treatments, a wild-type strain containing the GFP-Kar9p plasmid (MS4387), was grown to early exponential phase in synthetic complete minus leucine media containing 2% raffinose at 30°C. Nocodazole (Sigma Chemical Co.) was added to 15 μg/ml from a 1.5 mg/ml stock in DMSO. α Factor was added to 10 μg/ml from a 1 mg/ml stock in methanol. P*~GAL1~*-GFP--Kar9p expression was induced by the addition of galactose to a concentration of 2%. At the time of fixation, each treated culture was split and prepared either for indirect immunofluorescence with anti-tubulin or analysis of GFP-Kar9p localization with DAPI staining.

For hydroxyurea treatment, cells were grown to early exponential phase in synthetic complete minus leucine media containing 2% raffinose, 2% galactose, and 0.1% glucose. Hydroxyurea (Sigma Chemical Co.) was added to 100 mM for 3 h at 30°C. Cells were washed twice in prewarmed media and returned to 30°C. After 1 h 25 min, cells were fixed in formaldehyde (5 min), washed twice in PBS, and then scored for GFP-Kar9p localization. For all induction protocols, we observed no GFP-Kar9p fluorescent dots when galactose was not added to the media.

Results {#Results}
=======

KAR9 Is a Novel Gene
--------------------

In a collection of karyogamy mutants defective for nuclear congression, *kar9* was unique in exhibiting misoriented cytoplasmic microtubules in the zygote ([@B22]). In addition, we found that the *kar9* mutants were sensitive to the microtubule-destabilizing drug, benomyl. Growth was significantly suppressed at 15 μg/ml at 30°C (data not shown). In contrast, wild type was resistant to 25 μg/ml benomyl. As described below, *kar9* mutants also showed mitotic defects consistent with a defect in nuclear migration. The karyogamy defect, the benomyl sensitivity, and the mitotic defect segregated together in five tetrads derived from meiotic crosses. Therefore, we considered it highly likely that each of these phenotypes was the result of the *kar9* mutation. These phenotypes also suggested that Kar9p might play a broader role in microtubule function. To investigate further, the wild-type *KAR9* gene was isolated by suppression of *kar9\'*s benomyl sensitivity. A *kar9-485* strain (MS2684) was transformed with a YCp-based yeast genomic library ([@B44]) and screened for plasmid-dependent benomyl resistance (20 μg/ml at 30°C). Three independent plasmids were recovered that suppressed both the benomyl sensitivity and mitotic defects of *kar9-485.* These plasmids contained inserts that overlapped by 5.8 kb (Fig.1). To identify the minimal complementing region, additional subclones were constructed and tested for their ability to complement *kar9-485\'*s benomyl sensitivity and mitotic defects. Subclones containing all or almost all of the *KAR9* ORF corrected the benomyl sensitivity defect (Fig. [1](#F1){ref-type="fig"}). In contrast, two subclones truncated at the NH~2~ terminus only partially suppressed the mitotic defect.

To determine that the region on the three overlapping plasmid inserts contained the authentic *KAR9* gene rather than an extragenic suppressor, the 2.1-kb SpeI/SpeI fragment within this region was used for linkage analysis (Fig. [1](#F1){ref-type="fig"}). Integration of this fragment on pMR2886 was used to mark the wild-type *KAR9* locus with *URA3.* When crossed to a *kar9* mutant, the marked allele segregated together with the benomyl resistance in 31 out of 32 tetrads analyzed (see Materials and Methods). These results indicate that the sequences contained on pMR2886 were tightly linked to and therefore derived from the authentic *KAR9* gene.

Hybridization methods demonstrated that *KAR9* mapped to the distal end of the left arm of chromosome XVI. DNA sequence analysis showed that *KAR9* was between *MDL2* and *PLC1* (Fig. [1](#F1){ref-type="fig"}). This sequence was subsequently confirmed by the *S. cerevisiae* genome sequencing project. *KAR9* potentially encoded a 644--amino acid, 74-kD protein (Fig. [2](#F2){ref-type="fig"}) that showed no significant homology to any known proteins in available databases using BLAST or FASTA programs ([@B35]). Kar9p is predicted to be a basic protein with an overall calculated average isoelectric point (pI) of 8.9. However, the NH~2~-terminal 175 amino acids is predicted to be very acidic with an average calculated pI of 4.1. The COOH half of the protein contains three regions, which are predicted to be very basic, each with a calculated pI \> 11.4 (Fig. [2](#F2){ref-type="fig"}). This bipolar distribution of electrostatic charges is similar to that of the microtubule-associated protein, MAPU ([@B1]). The COOH-terminal third of the protein is also predicted to be proline rich, containing ∼10% proline residues and three PXXP motifs, possibly indicating an interaction with SH3 proteins ([@B55]; [@B2]). Alternatively, basic and proline-rich regions are also characteristic of microtubule-binding proteins ([@B30]). However, the basic domain of Kar9p does not have sequence homology to other known microtubule-binding proteins, including TAU, MAPU, Kar3p, Mhp1p, Bik1p, and p150*^glued^*. Nevertheless, the possibility that Kar9p may possess a microtubule-binding domain is supported by the behavior of GFP-Kar9p described below. Together, these data indicate that *KAR9* is a novel gene.

KAR9 Is Not Essential for Life, but Is Required for Cytoplasmic Microtubule Orientation and Nuclear Migration
-------------------------------------------------------------------------------------------------------------

To determine if the *KAR9* gene product performs an essential function, we replaced the *KAR9* sequence encoding amino acids 7--644 with *LEU2* in haploid cells by homologous recombination using the one-step gene replacement method ([@B46]). The recovery of viable haploid colonies demonstrated that *KAR9* is not essential for life. As described below, the *kar9Δ* mutants exhibited the same array of phenotypes as the *kar9-485* point mutant, confirming the identification of the authentic *KAR9* gene. Given the defects in cytoplasmic microtubule orientation in zygotes and the benomyl sensitivity of mitotic cells, we next examined the nuclear migration and microtubule morphology of the *kar9Δ* mutant in detail.

To determine how early in the mating process the defects were evident, we examined nuclear positioning and microtubule orientation in *kar9Δ* mutant shmoos. First, *kar9Δ* mutants were arrested with α factor and scored for nuclear position using DAPI stain. In wild-type shmoos, the nucleus normally moves up to the neck of the pear-shaped shmoo in preparation for mating ([@B6]; [@B41]; [@B38]). Confirming this observation, we found that in 93% of wild-type shmoos with projections (*n* = 401), the nuclei were in or at the neck of the shmoo (Table [III](#TIII){ref-type="table"}). Like wild type, the nuclei of dynein mutants were positioned correctly in 94% of shmoos (*n* = 400). In contrast, the nuclei of *kar9Δ* mutants were found in the center of the cell in ∼60% of shmoos (*n* = 300 and *n* = 324). We next used indirect immunofluorescence microscopy to examine the microtubules in the shmoo. In wild-type shmoos, 85% or more of the cells had microtubule bundles that extended to the shmoo tip (Fig. [3](#F3){ref-type="fig"} *A*). In contrast, 73% of the *kar9Δ* mutant shmoos had misoriented microtubule bundles that did not extend into the shmoo tip (Fig. [3](#F3){ref-type="fig"} *D*). Thus, the mating defect of the *kar9* mutant is likely to be the result not only of the failure of cytoplasmic microtubules within the zygote to interdigitate, but also of an earlier defect in which cytoplasmic microtubules were misoriented in the shmoo.

Because *kar9* mutants are sensitive to benomyl and because microtubule orientation is important during mitosis, we examined the *kar9* mutants for nuclear positioning defects in mitosis. First, cultures of asynchronously growing *kar9* cultures were stained with DAPI and scored for defects in nuclear location (Fig. [3](#F3){ref-type="fig"}, *J--L*). *kar9* mutants exhibited significantly increased frequencies of abnormal mitotic phenotypes in large-budded cells. These included cells that contained a single nucleus that had failed to migrate to the bud neck (Fig. [3](#F3){ref-type="fig"} *J*), cells with mitosis occurring within the mother cell (Fig. [3](#F3){ref-type="fig"} *K*), and cells with two nuclei within the mother cell (Fig. [3](#F3){ref-type="fig"} *L*). Anucleate cells were rarely seen (\<0.5%) in *kar9* mutant cultures. Cells exhibiting these three defects usually totaled between 10 and 15% of the culture at 30°C (Table [IV](#TIV){ref-type="table"}). In contrast, wild-type cells showed only 2--3% of such abnormal cells. Because similar defects were reported for *dhc1* mutants ([@B12]; [@B23]), we compared directly the nuclear migration defects observed in *dhc1* with those of *kar9* (Table [IV](#TIV){ref-type="table"}). While the *dhc1* mutant phenotypes were less severe at 30°C, the magnitude of the defects for both strains was aggravated by growth in the cold, with the sum of all defects increasing to \>20% at 12°C. Thus, both *dhc1* and *kar9* exhibited strikingly similar defects in nuclear positioning (Table [IV](#TIV){ref-type="table"}).

Indirect immunofluorescence was carried out to determine if the *kar9Δ* mutant exhibited mitotic nuclear migration defects that correlated with microtubule abnormalities. Exponentially growing cultures of *kar9* mutants contained many cells with abnormal microtubule morphologies for both the mitotic spindle and the cytoplasmic microtubules (Fig. [3](#F3){ref-type="fig"} *G*). The mitotic spindle was often rotated away from the long axis of the mother--bud. Occasionally, the spindle appeared bent along the inner surface of the mother cell (data not shown), similar to that observed in other nuclear migration mutants, *DHC1*/*DYN1* ([@B12]; [@B23]), *ACT5* ([@B7]; [@B31]), and *JNM1* ([@B29]). The cytoplasmic microtubules were also frequently positioned aberrantly in *kar9* mutants (Fig. [3](#F3){ref-type="fig"} *G*). In contrast to both wild-type and *dhc1Δ* cells, 30% of *kar9Δ* cells carrying out anaphase within the mother cell had cytoplasmic microtubules that failed to extend into the bud (Fig. [4](#F4){ref-type="fig"} *A*). In those *kar9Δ* cells that contained two nuclei within the mother cell, 70% exhibited cytoplasmic microtubules that did not extend into the bud (Fig. [4](#F4){ref-type="fig"} *B*). This is in sharp contrast to the phenotype of equivalent *dhc1Δ* mutant cells, in which 83% of the cytoplasmic microtubule bundles were observed to extend into the bud (Fig. [4](#F4){ref-type="fig"} *B*; [@B23]).

The *kar9Δ* mutants displayed no obvious actin defect by rhodamine-phalloidin staining. In *kar9*, actin patches localized to the growing bud in small-budded cells and to the cleavage furrow in cells undergoing cytokinesis as they normally do in wild type (data not shown). From this, together with the benomyl sensitivity, we conclude that the *kar9* mutation affects the functions of cytoplasmic microtubules.

kar9Δ and dhc1Δ Mutants Are Synthetically Lethal
------------------------------------------------

Because *kar9* and *dhc1* display similar phenotypes in nuclear migration, we wanted to determine whether *KAR9* functions in the same or different pathways as other genes involved in this process. To carry out the analysis, marked deletions of *KAR9* and several other nuclear migration genes were crossed together.

The first nuclear migration protein tested was the microtubule motor protein, dynein, encoded by *DHC1*/*DYN1.* To make the *kar9Δ dhc1Δ* mutant, the *dhc1Δ* strain (MS4262) was crossed to *kar9-Δ1::LEU2* (MS4589). Of the 35 segregants predicted to be double mutants on the basis of segregation of markers in sister spores, 9% failed to germinate and 91% formed microcolonies (Table [V](#TV){ref-type="table"}; Fig. [5](#F5){ref-type="fig"}, *A* and *B*) at 30°C. In contrast, wild-type and single mutant colonies showed 97% spore viability and no apparent growth defects (data not shown). The microcolonies exhibited heterogeneity in size, but by 3--4 d after germination at 30°C they usually attained the size of an 18--24-h-old wild-type colony (e.g., \<1,000 cells). Examination of the cells within these microcolonies by DAPI staining and Nomarski optics revealed a wide range of defects. Most cells were multinucleate, anucleate, deformed in cell shape, or lysed. These defects are consistent with a severe defect in nuclear migration (Fig. [5](#F5){ref-type="fig"} *B*).

Several genes, including *ACT5* and *JNM1*, have been suggested to operate in nuclear migration in concert with the dynein heavy chain as part of the dynactin complex ([@B29]; [@B31]). If such a model is correct, then deletions in these genes would be predicted also to result in synthetic lethality when combined with the *KAR9* deletion. To test this possibility, the *jnmΔ* strain (MS4321) was crossed to the *kar9-Δ2::HIS3* strain (MS4587) to create *kar9Δ jnm1Δ* mutants. Seventeen tetrads were examined, yielding 14 predicted double mutants. Of these, 100% formed microcolonies (Table [V](#TV){ref-type="table"}). To create *kar9Δ act5Δ* double mutants, the *ACT5* delete strain (MS4586) was crossed to the *kar9-Δ1::LEU2* strain (MS4263). From this cross, 23 tetrads were dissected, producing 20 predicted double mutants. Of these double mutants, 5% were dead and 95% formed microcolonies (Table [V](#TV){ref-type="table"}). Like the *kar9Δ dhc1Δ* double mutant, analysis of the cells within these microcolonies also revealed lysed cells, anucleate cells, and multinucleate cells. In contrast, *dhc1 act5*, *dhc1 jnm1*, and *act5 jnm1* double mutants are viable and show no more severe defect than any single mutant (Tatchell, K., personal communication; [@B31]; [@B15]). We conclude therefore that Kar9p acts in a nuclear migration pathway that is separate from and partially redundant with that of the dynein/dynactin complex.

Several additional genes were also tested for the possibility of genetic interactions with *kar9Δ*. A bilateral karyogamy mutation, *bik1* ([@B3]), with additional functions during mitosis, also exhibited a microcolony phenotype in combination with *KAR9* deletions (Table [V](#TV){ref-type="table"}). Cells found within the microcolonies of the *kar9Δ bik1-518* ([@B49]) double mutant (Fig. [5](#F5){ref-type="fig"} *C*) exhibited defects similar to those of the *kar9Δ dhc1Δ* mutant.

To test the specificity of the synthetic lethality, crosses to mutants in other microtubule motor proteins were performed. *KIP1* ([@B40]) and *CIN8* ([@B17]) are required for establishment of a bipolar mitotic spindle. *kar9Δ cin8Δ* and *kar9Δ kip1Δ* double mutants resulted in no detectable growth defect (Table [V](#TV){ref-type="table"}). *KAR3* is required for mitosis and mating, possibly by mediating the sliding of microtubules past each other ([@B30]). The *kar9Δ kar3Δ* mutant spores exhibited no obvious growth defect worse than that of the *kar3Δ* single mutant alone. Deletions in *SMY1*, a kinesin involved in secretion ([@B24]), also exhibited no apparent growth defect when combined with the *KAR9* deletion (Table [V](#TV){ref-type="table"}).

GFP-Kar9p Localizes to the Tip of the Shmoo
-------------------------------------------

To better understand how Kar9p might be functioning, its localization was determined inside living yeast cells. A GFP-Kar9p fusion protein was constructed on a centromere-based plasmid with its expression under the control of the *GAL1* promoter (pMR3465). This construct fully suppressed the microtubule orientation and nuclear migration defects in *kar9Δ* shmoos (data not shown). The localization of GFP-Kar9p was examined in shmoos and zygotes. In each instance, GFP-Kar9p fluorescence was observed primarily as a single small dot. In 73% of *kar9Δ* shmoos, the dot was located at the tip of the shmoo projection (*n* = 152) (Fig. [6](#F6){ref-type="fig"} *A*). In an additional 12% of the shmoos, a thin line extended from the single dot toward the nucleus (data not shown). Identical results were observed in wild-type cells expressing GFP-Kar9p. In zygotes, GFP-Kar9p was located as an elongated dot at the future site of cell fusion of the pre-zygote (100%; *n* = 15) (Fig. [6](#F6){ref-type="fig"} *D*), as if two dots had fused. In budded zygotes, it was also found at the tip of the emerging bud (Fig. [6](#F6){ref-type="fig"} *G*).

GFP-Kar9p Localization to the Tip of the Bud Is Cell-Cycle Dependent
--------------------------------------------------------------------

To gain an understanding of how Kar9p might be functioning to orient microtubules in mitotically growing cells, the localization of GFP-Kar9p was scored throughout the cell cycle. First, asynchronously growing cultures were examined using bud size and nuclear position as an indicator of the cell cycle stage. In unbudded cells, little or no GFP localization was observed (76%; *n* = 51) (Figs. [7](#F7){ref-type="fig"} *A* and [8](#F8){ref-type="fig"}). In small--medium-budded cells, the majority of cells showed GFP-Kar9p localization as a single dot at the tip of the growing bud (58%; *n* = 57) (Figs. [7](#F7){ref-type="fig"} *D* and [8](#F8){ref-type="fig"}). An additional 14% of small-budded to medium-budded cells also had the dot at the tip of the bud with a second dot between the first cortical dot and the nucleus (Fig. [8](#F8){ref-type="fig"}). At anaphase, the major localization pattern (49% of all anaphase cells; *n* = 57) was a single dot of GFP at the tip of the bud (Figs. [7](#F7){ref-type="fig"} *G* and [8](#F8){ref-type="fig"}). An additional 14% had the dot at the tip of the bud, but also had a second dot between the cortical dot and the nucleus (Fig. [8](#F8){ref-type="fig"}). For the small-budded and anaphase stages, the percentage of cells that showed no localization was relatively low, 19 and 30%, respectively (Fig. [8](#F8){ref-type="fig"}). However at telophase, the majority of cells exhibited no localization (58%; *n* = 80) (Figs. [7](#F7){ref-type="fig"} *J* and [8](#F8){ref-type="fig"}). To confirm the latter stages of localization, cells were first synchronized with hydroxyurea, and then released from the block. Under these conditions, \>85% of telophase cells showed no localization (*n* = 70). In comparison, only 17% of anaphase cells exhibited no localization at the corresponding time point (*n* = 88) (Fig. [8](#F8){ref-type="fig"}). In addition to the single dot in the bud and the "two dots in a line" patterns (Fig. [8](#F8){ref-type="fig"}), some cells also exhibited an additional spot. These cells were classified as "other" (Fig. [8](#F8){ref-type="fig"}). The additional spot was located at one of the six locations depicted in Fig. [7](#F7){ref-type="fig"} *M* in \>90% of cells in the "other" category. In a few rare examples, three spots per cell were observed. We conclude that GFP-Kar9p shows both mother--daughter asymmetry and cell cycle dependence for its localization.

Cytoplasmic Microtubules Intersect the GFP-Kar9p Dot
----------------------------------------------------

To determine the relationship between cytoplasmic microtubules and the GFP-Kar9p dot, double-label indirect immunofluorescence was conducted using antibodies specific for tubulin and GFP. In shmoos, the cytoplasmic microtubule bundle terminated at the dot of anti-GFP staining in all cases (*n* = 100) (Fig. [9](#F9){ref-type="fig"}, *A--D*). In vegetative cells, microtubule staining intersected the anti-GFP staining dot in 85% of the large-budded cells examined (*n* = 20; Fig. [9](#F9){ref-type="fig"}, *E--H*). In a small percentage of both shmoos and large-budded cells, a line of anti-GFP immunofluorescence extended away from the anti-GFP dot toward the nucleus. In all cases, the line of staining colocalized with the cytoplasmic microtubules.

GFP-Kar9p Localization at the Cortex Is Independent of Microtubules
-------------------------------------------------------------------

Kar9p might function in microtubule orientation by two different mechanisms. In the first model, Kar9p might function as a microtubule-associated protein which stabilizes cytoplasmic microtubules. Localization of Kar9p at the cortex would therefore be dependent solely on the cytoplasmic microtubules. Alternatively, Kar9p might instead serve as a target for the cytoplasmic microtubules at the cortex. In this second model, Kar9p localization would be solely dependent on cortical information and independent of microtubules.

To examine these possibilities and to ascertain whether microtubules are required for the maintenance of Kar9p localization, wild-type shmoos already expressing GFP-Kar9p were treated with nocodazole to depolymerize preexisting microtubules (Fig. [10](#F10){ref-type="fig"} *B*) or mock-treated with DMSO (Fig. [10](#F10){ref-type="fig"} *A*). 74% of shmoos treated with nocodazole under these conditions had a GFP-Kar9p dot at the tip of the shmoo, as compared to 90% of the mock-treated control shmoos. Thus, Kar9p remained at the tip of these shmoos and microtubules were not required to maintain GFP-Kar9p at its cortical location. Alternatively, microtubules might play a role in establishing the localization of GFP-Kar9p at its cortical site. To investigate this possibility, cells were induced to form shmoos either in the presence (Fig. [10](#F10){ref-type="fig"} *C*) or absence of microtubules (Fig. [10](#F10){ref-type="fig"} *D*) and the expression of GFP-Kar9p was then induced. GFP-Kar9p localization was found at the tip of 72% of shmoos treated with nocodazole versus 85% of shmoos mock treated with DMSO. Thus, under microtubule-depolymerizing conditions, GFP-Kar9p was still able to localize to the tip of the shmoo. Identical results were obtained using the GFP-KAR9 plasmid in a *kar9* deletion strain.

A similar analysis was carried out to determine if GFP-Kar9p localization was also independent of microtubules in vegetative cells. When microtubules were depolymerized after induction of GFP-Kar9p, localization was found at the tip of the bud in 89% of large-budded cells (Fig. [10](#F10){ref-type="fig"} *F*). In comparison, in the mock-treated controls, 72% had the GFP-Kar9p dot at the tip of the large bud (Fig. [10](#F10){ref-type="fig"} *E*). Similarly, when microtubules were depolymerized before the induction of GFP-Kar9p, 79% of large-budded cells contained a dot of GFP-Kar9p localization at the tip of the bud (Fig. [10](#F10){ref-type="fig"} *H*). Thus, without microtubules present, GFP-Kar9p could still localize at the tip of the bud. Therefore, we conclude that like shmoos, Kar9p localization at the cortex was independent of microtubules in vegetative cells.

In 11 and 12% of the mock-treated control cells, a line of GFP-Kar9p localization extending from the cortex was also observed (Fig. [10](#F10){ref-type="fig"}, *E* and *G*). When cells were treated with nocodazole, none of the cells displayed the line of GFP-Kar9p fluorescence (Fig. [10](#F10){ref-type="fig"}, *F* and *H*). In the experiment with shmoos, a GFP-Kar9p dot with a line of fluorescence was scored in the "cortical dot" category. When the shmoos were treated with nocodazole, the lines of GFP-Kar9p fluorescence were not observed (data not shown). Therefore, localization along microtubules was dependent on their polymerization. These data support the finding that the line of GFP-Kar9p fluorescence colocalized with microtubules (Fig. [9](#F9){ref-type="fig"}) and are consistent with the idea that Kar9p may contain a microtubule-binding domain.

Discussion {#Discussion}
==========

In this paper we have shown that *KAR9* encodes a novel protein that is required for nuclear migration during mitosis and mating. Loss of Kar9p results in misoriented cytoplasmic microtubules, which appears to be the primary cause of the nuclear migration defect. Genetic analysis revealed that deletion mutations in *KAR9* and genes encoding components of the dynactin complex are synthetically lethal. GFP-Kar9p localized to cortical sites in buds and shmoos. Consistent with a role for Kar9p in orienting the microtubules, the cytoplasmic microtubules intersected the GFP-Kar9p dot. The localization of GFP-Kar9p to the bud tip was cell cycle dependent, indicating that localization was both spatially and cell cycle regulated. Finally, the microtubule independence of the cortical localization of Kar9p indicates that it can respond directly to the spatial information present in the growing cell.

Nuclear Migration Defects and Misoriented Microtubules in kar9 Mutants during Mating
------------------------------------------------------------------------------------

*kar9* was previously identified as a karyogamy mutant with a class I nuclear fusion defect characterized by widely separated nuclei in the zygote ([@B22]). However, the *kar9* mutant was unlike other class I karyogamy mutants in that its cytoplasmic microtubules were grossly misoriented. We have now examined *kar9* mutants at the shmoo stage and found that the defect occurs before the time of cell fusion. Unlike wild type or *DHC1* mutants, a significant number of *kar9* nuclei did not move to the neck of the shmoo in response to pheromone treatment (Table [III](#TIII){ref-type="table"}). Examination of the microtubules in *kar9* shmoos revealed that the microtubules were misoriented (Fig. [3](#F3){ref-type="fig"}). It seems reasonable to conclude that the defect in nuclear fusion arises from the earlier defect in nuclear migration. Presumably the cytoplasmic microtubules from misoriented nuclei are unable to intersect and pull the nuclei together in the limited time available for nuclear fusion in the zygote.

Mating cells represent a simpler system than mitotically growing cells in which to identify cellular components. For instance, the kinesin-like motor, Kar3p, is one example of a nonredundant gene required for functions in the shmoo and zygote and deletion of *KAR3* results in complete blockage of nuclear migration in the zygote. Hence, it is likely to be the sole motor responsible for nuclear migration in zygotes. The very high incidence of misoriented microtubules in *kar9Δ* shmoos suggests that Kar9p is the major, if not the only, mechanism involved in orienting cytoplasmic microtubules toward the tip of the shmoo projection.

The Role Played by KAR9 in Nuclear Migration in Mitosis Is Different Than the Role Played by the Dynein Heavy Chain Motor
-------------------------------------------------------------------------------------------------------------------------

Mitotically growing *kar9* mutants also displayed severe nuclear migration defects. The cytoplasmic microtubules were also misoriented in the mitotic example of nuclear migration defect. Because the cytoplasmic microtubules are required for nuclear migration in mitotic cells ([@B48]), the most likely explanation for the defect in *kar9* mutants is the abnormally oriented cytoplasmic microtubules. Our results indicate that Kar9p function is not specific to either the mating or mitotic processes. Rather, Kar9p must function in microtubule orientation in general and that microtubule orientation is Kar9p\'s primary function.

Several pieces of evidence strongly suggest that Kar9p plays a very different role in nuclear migration than Dhc1p. First, Kar9p functions both during mating and mitotic cell divisions. The *dhc1* mutants do not exhibit a mating defect ([@B23]), and *dhc1* mutants do not display nuclear migration defects in the shmoo (Table [III](#TIII){ref-type="table"}). These results are consistent with the earlier view that Kar3p is the minus end--directed microtubule motor responsible for nuclear migration during mating. Second, in *kar9* mutants the cytoplasmic microtubules do not enter the bud, whereas in *dhc1* cells the cytoplasmic microtubules consistently extend into the bud (Muhua et al., 1993; [@B15]). This result is consistent with the view that Kar9p is responsible for orientation, whereas dynein is required for movement.

Genetic interactions between *kar9Δ* and *dhc1Δ* suggest that *KAR9* functions in a pathway that is separate and partially redundant with *DHC1.* The double mutants between *kar9* and *dhc1* were severely handicapped for growth in comparison to the minor growth defects of either single mutant alone (Fig. [5](#F5){ref-type="fig"}). Furthermore, *kar9* was synthetically lethal with deletions in two other components postulated to act with dynein, *ACT5* and *JNM1* ([@B29]; [@B31]). Importantly, double mutants between deletions in *DYN1*, *ACT5*, and *JNM1* have been reported to be no worse than the single mutants for nuclear migration defects. These data are consistent with the model that *DHC1*/*DYN1*, *ACT5*, and *JNM1* function in the same pathway (Tatchell, K., personal communication; [@B31]; [@B15]).

Synthetic lethality can be observed in two very different kinds of genetic interactions. On the one hand, two mutations might cause the disruption of one essential complex. For example, each point mutation might only reduce the stability of the complex. However together the two mutations could greatly reduce the stability such that the complex never forms. In this case, one might expect complete deletions of proteins to be lethal. On the other hand, two mutations might disrupt the function of two redundant pathways required for an essential process. In this case neither gene would be essential.

The use of deletion strains in these studies demonstrated that neither *KAR9* nor *DHC1*/*DYN1* are essential. We therefore interpret the synthetic lethality between *kar9* and mutants in the dynein pathway as a reflection of their respective functions in separate pathways required for the essential process of nuclear migration. The converse side of this argument suggests that *kar9* deletions are not disrupting the dynein complex, as would be expected if a dynein intermediate chain were removed. If this were the case, the expected phenotype would be the same as if the dynein heavy chain itself had been removed and the phenotype of double mutant would be no worse than that of either single deletion. Therefore, we conclude that the synthetic lethality exhibited between *kar9Δ* and *dhc1Δ* cannot be the result of Kar9p functioning as an intermediate chain or similar accessory subunit to the dynein heavy chain. Indeed, Kar9p does not have homology to any known dynein intermediate chains. Therefore, Kar9p must be functioning in a manner that is distinct from that of the pulling force of the dynein heavy chain.

If Kar9p\'s microtubule orientation function is separate from dynein\'s microtubule pulling function, why then are *KAR9* and *DHC1* not essential? That is, what functions do each provide in the absence of the other protein? We postulate that Kar9p stably orients the cytoplasmic microtubules while dynein pulls. In Kar9p\'s absence and without proper microtubule orientation, dynein and/or other motors hypothesized to be located on the cortical surface would not pull efficiently. However, when microtubules transiently enter into the bud, then the motors could provide some force and orientation, which over time would provide sufficient nuclear migration for most cells. In Dhc1p\'s absence, Kar9p would still provide stable microtubule orientation. Without Dhc1p, it is possible that additional motor systems such as Kip2p and Kip3p may be involved in moving the nucleus into the bud and thus may compensate for the loss of dynein\'s pulling force (Miller, R., K. Heller, D. Wallack, L. Frisén, D. Loayza, and M.D. Rose, manuscript in preparation; Miller, R.K., and M.D. Rose. 1995. *Mol. Biol. Cell*. 6:256a. 1995. [@B9]; [@B11]). Alternatively, the intrinsic dynamic instability of microtubules might provide sufficient force for the nuclear migration, much as depolymerization can move chromosomes on microtubules in vitro ([@B21]; [@B25]). However, the cumulative effect of the loss of both Kar9p and Dhc1p is that without the correct orientation of cytoplasmic microtubules, any additional force that might be provided by auxiliary motors or by microtubule depolymerization is ineffectual. The cell then loses both the pulling force and correct microtubule orientation, resulting in a massive failure of nuclear migration.

GFP-Kar9p Localization
----------------------

Using a GFP-Kar9p fusion, we found Kar9p localized to a distinct dot at the tip of the shmoo and at the tip of the growing bud. We never found GFP-Kar9p localization to be diffuse or spread out in a patch over the cortical surface. However, in minor localization patterns we did see a line of localization extending proximally toward the nucleus. Unlike the GFP-Kar9p cortical dot, the line of localization was dependent on microtubules. This may reflect an association of Kar9p with cytoplasmic microtubules, perhaps through the basic domain of Kar9p. Furthermore, since cytoplasmic microtubules terminated with the GFP-Kar9p dot, Kar9p is positioned at the predicted cellular location to orient cytoplasmic microtubules.

In addition to the strong mother--bud asymmetry, GFP-Kar9p also showed cell cycle variation. In unbudded cells when microtubule orientation is presumably not needed, localization was not observed. Kar9p was found at the tip of small-budded cells and remained at the bud tip through anaphase. At telophase, GFP-Kar9p localization was no longer observed. Why might it no longer be necessary for Kar9p to be localized at the tip of the bud after anaphase? At anaphase, the orientation of the nucleus through the neck of the bud has been clearly established. Using live cell observations with differential interference contrast microscopy, [@B54] demonstrated that after migration of the two nuclei to the distal ends of the cell and bud (and extension of the mitotic spindle to its maximal length), the nucleus then returns to the center of the cell. It could be possible that this "rebound" to the center of the cell requires that the Kar9p tether release the microtubule from the cortex.

How does GFP-Kar9p localization disappear after anaphase? One possibility is that Kar9p is degraded, perhaps through the anaphase promoting complex ubiquitination system. Alternatively, delocalization of GFP-Kar9p away from the spot might prevent its visualization. Either mechanism would have to overcome the continuous galactose-induced expression from the *GAL1* promoter used in these experiments. Nevertheless, Kar9p is localized both when and where it would be predicted to function in orienting microtubules into the bud.

In a subset of cells additional spots of GFP localization were observed. All of these can be represented by subsets of the six GFP-Kar9p dots shown in Fig. [7](#F7){ref-type="fig"} *M*, with two to three dots being the most prevalent minor class (Fig. [8](#F8){ref-type="fig"}). However, because of the impracticality of showing all combinations of six dots scored three ways, we show this very rare cell as an example. One site of minor localization was to the nuclear periphery, most likely at the SPB. GFP-Kar9p localization at the nucleus is likely to represent an overexpression phenotype, since this localization was greatly reduced when GFP-Kar9p expression levels were downregulated by the addition of glucose to the media and through the use of a *gal2* mutant (data not shown). GFP-Kar9p localization as two dots at each side of the neck in large-budded cells could represent an involvement of Kar9p at sites required for the microtubule-dependent reorientation of the nucleus to face the new bud site for the next cycle of axial budding ([@B4]; [@B47]). Alternatively, localization at the neck might represent premature association with the new bud site, before Kar9p\'s normal association at the tip of the new bud. Interestingly, the presence of these minor localization patterns did not appear to be affected by the depolymerization of microtubules by nocodazole (data not shown). Thus, whereas we interpret the significance of these minor localization sites with caution, they may represent the normal association of Kar9p with proteins of lower affinity. It is significant that each of these minor localization patterns are at locations within the cell that are important for microtubule function (Fig. [7](#F7){ref-type="fig"} *M*).

We were somewhat surprised to find that Kar9p did not normally localize to a mother cell cortical site as well; cytoplasmic microtubules are predicted to be anchored to the mother cell cortex as well as to the bud cortex. Without a mother cell cortical attachment, the nucleus might be pulled completely into the bud, leaving the mother cell without a nucleus. Num1p has been proposed to be involved in this function (Farkasovsky and Kuntzel, 1995). Num1p localizes as many punctate spots widely distributed primarily over the mother cell\'s cortical surface (Farkasovsky and Kuntzel, 1995). In contrast, Kar9p localizes as a single dot at the tip of the bud. However like *kar9* mutants, *num1* mutants do not always orient cytoplasmic microtubules into the bud correctly (Farkasovsky and Kuntzel, 1995).

Nocodazole Depolymerization of Microtubules
-------------------------------------------

By treating GFP-Kar9p--expressing cells with nocodazole, we have shown that the localization of Kar9p at the cortex is largely independent of microtubule polymerization. Microtubules are not required either for the establishment or the maintenance of GFP-Kar9p at the cortex. Therefore, Kar9p appears to carry out its microtubule orientation function via its own interaction with the cortex. This suggests that Kar9p does not function as a microtubule-associated "capping" protein. Rather it suggests that Kar9p provides an orientation function for cytoplasmic microtubules as part of the cortical cytoskeleton.

Since actin is an intrinsic element for many polarized functions in yeast, it is possible that Kar9p localization occurs through an association with the actin cytoskeleton. This hypothesis is consistent with previous observations that the orientation of the cytoplasmic microtubules occurs in response to cues from sites of polarized growth, and that microtubules are not involved in establishing this polarity ([@B19]; [@B38]; [@B53]).

Previous studies in a variety of organisms have proposed models in which the actin cytoskeleton and cortical structures in general serve to anchor cytoplasmic microtubules and orient the mitotic spindle ([@B18]; [@B10]; [@B34]; [@B48]). In *Caenorhabditis elegans* embryos, irradiation of a putative microtubule attachment point at the cortex disrupted the rotation of the mitotic apparatus and centrosomes, the functional equivalent of the yeast SPB ([@B18]). Micromanipulation of *Chaetopterus* oocytes demonstrated the existence of a single, localized spindle attachment point on the oocyte cortex ([@B27]). In *S. cerevisiae*, disruption of the actin network of cables and cortical actin patches at the nonpermissive temperature of *ACT1-4* results in a rapid deorientation of previously oriented pre-anaphase spindles ([@B34]). However, the nature of the postulated microtubule attachment complex to the cortex remains elusive. The results reported here indicate that Kar9p should be considered for such a role. Whether Kar9p interacts directly with the actin cytoskeleton, indirectly through an actin-binding protein, or interacts with the bud cortex through some other attachment mechanism remains an interesting avenue of future investigation.

Mitosis comprises many critical steps. Universal in all systems is the establishment of the mitotic spindle in the correct orientation relative to the plane of cell division. In *S. cerevisiae*, spindle orientation is coordinated with the migration of the nucleus to the bud neck. We report here that Kar9p functions both in vegetatively growing cells and in shmoos as a part of an orientation mechanism for cytoplasmic microtubules. In both instances of polarized growth, Kar9p orients cytoplasmic microtubules toward the cell cortex. Therefore, we propose that the novel cortical protein, Kar9p (either directly or as part of a complex) is involved in anchoring cytoplasmic microtubules to the cell cortex and thus provides a mechanism for spindle orientation. We consider it likely that Kar9p-like adaptors will be found in other systems.
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DAPI
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:   yeast peptone dextrose
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List of Yeast Strains Used in This Study

  Strain       Genotype                                                                                    Source
  --------- -- ---------------------------------------------------------------------------------------- -- ------------
  MS52         *MATα leu2-3 leu2-112 trp1-Δ1 ura3-52*                                                      Rose
  MS810        *MAT* **a**/*α ura3-52/ura3-52 ade2-101/*+ *leu2-3 leu2-112/leu2-3 leu2-112 trp1-Δ1/*+      Rose
  MS1556       *MAT* **a** *ura3-53 leu2-3 leu2-112 ade-2-101 his3-Δ200*                                   Rose
  MS1614       *MATα kar3-Δ::LEU2 ura3-52 leu2-3 leu2-112 his3-Δ200 ade2-101* {*KAR3 URA3 CEN4 ARS1*}      Rose
  MS2305       *MAT* **a** *kip1-1::URA3 ura3-52 leu2-3 leu2-112 trp1-Δ1*                                  Rose
  MS2684       *matΔ::LEU2 kar9-485 ura3-52 leu2-3 leu 2-112 trp1-Δ1 his3::TRP1*                           Rose
  MS3662       *MAT* **a** *kar9-485 leu2-3 leu2-112 ura3-52*                                              This study
  MS4062       *MATα kar9-Δ1::LEU2 ura3-52 leu2-3 leu2-112 trp1-Δ1*                                        This study
  MS4262       *MATα dhc1-Δ::URA leu2-3 leu2-112 trp1-Δ1 ura3-52*                                          This study
  MS4263       *MAT* **a** *kar9-Δ1::LEU2 ura3-52 leu2-3 leu2-112 ade2-101 his3-Δ200*                      This study
  MS4306       *MAT* **a** *kar9-Δ2::HIS3 ura3-53 leu2-3 leu2-112 ade2-101 his3-Δ200*                      This study
  MS4313       *MAT* **a** *kar9-Δ1::LEU2 leu2-3 leu2-112 ura3-52 trp1-Δ1*                                 This study
  MS4316       *MATα kar9-Δ1::LEU2 ura3-52 leu2-3 leu2-112 ade2-101 his3-Δ200*                             This study
  MS4321       *MAT* **a** *jnm1::LEU2 ura3-52 leu2-3 leu2-112 ade2-101 his3-Δ200*                         This study
  MS4382       *MAT* **a** *kar9-Δ2::HIS3 ura3-53 leu2-3, leu2-112 ade2-101 his3-Δ200* {*pMR3465*}         This study
  MS4387       *MAT* **a** *ura3-52 leu2-3 leu2-112 ade2-101 his3-Δ200* {*pMR3465*}                        This study
  MS4516       *MAT* **a** *kip3-Δ::HIS3 ura3-52 leu2-3 leu2-112 ade2-101 his3-Δ200*                       Rose
  MS4586       *MATα act5-Δ1::HIS3 ura3-52 lys2-801 ade2-101 trp1-Δ63 his3-Δ200 leu2-Δ1*                   This study
  MS4587       *MATα kar9-Δ2::HIS3 ura3-53 leu2-3 leu2-112 his3-Δ200 trp1-Δ1*                              This study
  MS4589       *MAT* **a** *kar9-Δ1::LEU2 ura3-52 leu2-3 leu2-112 ade2-101 his3-Δ200*                      This study
  MS4671       *MATα leu2-3 leu2-112 trp1-Δ1 ura3-52* {*pMR3465*}                                          This study
  MS4683       *MAT* **a** *dhc1Δ::URA trp1-Δ1 leu2-3, leu2-112 ura3-52*                                   This study
  MS4734       *MATα bik1::TRP leu2-3, leu2-112 trp1-Δ1 ura3-52*                                           This study
  MS4903       *MAT* **a** *dhc1-Δ::LEU2 ura3-52 leu2-3 leu2-112 ade2-101 his3-Δ200*                       This study
  APY4ΔD5      *MAT* **a** *smy1-Δ::URA leu2-3 leu2-112 ura3-52 trp1 ade2 his6*                            Lillie
  MAY2058      *MATα cin8::LEU2 leu2-3 leu2-112 his3-Δ200 ura3-52 lys2-801*                                Hoyt
  YJC1159      *MATα act5-Δ1::HIS3 ura3-52 lys2-801 ade2-101 trp1-Δ63 his3-Δ200 leu2-Δ1*                   Cooper

###### 

List of Plasmids Used in This Study

  Strain       Genotype/Description                                     Source
  --------- -- ----------------------------------------------------- -- ------------
  pMR2254      pUC18 carrying the *LEU2* yeast selectable marker        Rose
  pMR3143      *KAR9 HIS3 CEN6 ARS AMP^R^*                              Rose
  pMR3381      *KAR9 AMP^R^ URA3* integrating plasmid                   This study
  pMR3382      *kar9-Δ1::LEU2 URA3 AMP^R^*                              This study
  pMR3386      *kar9-Δ2::HIS3 URA3 AMP^R^*                              This study
  pMR3465      *P~GAL1~-GFP-KAR9 CEN4 ARS1 LEU2 AMP^R^*                 This study
  pMR2886      2.1-kb SpeI-SpeI fragment cloned into pRS406             This study
  pB886        plasmid carrying the *HIS3* yeast-selectable marker      Broach
  pB1893       *P~GAL1~-GFP CEN4 ARS1 LEU2 AMP^R^*                      Broach
  pRS406       *URA3 AMP^R^* integrating plasmid                        Sikorski
  pJM1432      *jnm1::LEU2* disruption plasmid                          Tatchell
  pBR2-1U      *dhc1::URA3* disruption plasmid                          Bloom
  pMR3861      *dhc1::LEU2* disruption plasmid                          Bloom
  pVB17        *bik1::TRP* disruption plasmid                           Fink

![Map of *KAR9* clones and *kar9* deletions. The region of overlap between the two original genomic library plasmids is shown by the hatched bar. Subclones were constructed and tested for their ability to suppress *kar9\'*s benomyl sensitivity (20 μg/ml at 30°C) and its nuclear migration defect, which was scored by DAPI. The integration plasmid (pMR2886), linearized with BglII, was used for linkage analysis. In the deletion vector (pMR3382), *LEU2* replaces the *KAR9* sequence from the BglII to the second SpeI site. In the deletion vector (pMR3386), *HIS3* replaces the *KAR9* sequence from the BglII sequence to BamHI. Numbering begins ∼100 bp upstream of the start of the *MDL2*-coding region. Restriction sites are represented as follows: *S*, SalI; *BH*, BamHI; *Xh*, XhoI; *K*, KpnI; *Bg*, BglII; *P*, PvuII; *Sp*, SpeI; *Mu*, MluI. Vector sequences are represented by thin lines.](JCB32925.f1){#F1}

![Kar9p sequence features. (*A*) Structural representation of Kar9p domains. Vertical-striped region represents the acidic domain of Kar9p. The horizontal-striped region represents the putative coiled-coil. The diagonally striped areas represent the highly basic region. The solid region represents the proline-rich domain, which roughly coincides with the basic domain. (*B*) The Kar9p protein sequence. Underlined region represents the acidic domain of Kar9p. Dotted line represents the putative, possible coiled-coil region of the protein. Double-underlined region represents the highly basic region. Three PXXP motifs are shown in italics. *KAR9* corresponds to ORF YPL269W of the yeast genome sequencing project. These sequence data are available from GenBank/EMBL/DDBJ under accession number [AF034763](AF034763).](JCB32925.f2){#F2}

###### 

Nuclear Migration Defect in kar9Δ Shmoos

  ---------------- -- ----- -- ----- -- -------- -- -----
  Wild type           93%       6%      0.5%        401
  *kar9Δ2::HIS3*      37%      60%          3%      324
  *kar9Δ1::LEU2*      40%      57%          3%      300
  *dhc1Δ*             94%       6%      0.5%        400
  ---------------- -- ----- -- ----- -- -------- -- -----

Wild type (MS1556), *kar9Δ* strains (MS4306 and MS4263), and *dhc1Δ* strain (MS4683) were arrested for 3 h with α factor. Cells were fixed, stained with DAPI, and then scored for nuclear position. Results are shown for a single experiment. Similar results were obtained for cells arrested for 90 min (data not shown).  

![*kar9* defects: aberrant cytoplasmic microtubules and nuclear migration. Wild-type (*A--C*) (MS1556) and *kar9Δ* (*D--F*) (MS4306) shmoos, as well as *kar9-485* vegetatively growing cells (*G--I*) (MS2684) were fixed for indirect immunofluorescence using rabbit anti-tubulin (*G*) or rat anti-tubulin YOL1/34 (*A* and *D*). Examples two of vegetative *kar9-485* cells with abnormal microtubules are shown in the composite panels, *G--I. J--L* are DAPI and Nomarski double-exposure images illustrating the array of abnormal mitotic phenotypes found in the *kar9-485* stain, MS2684, grown to early logarithmic phase at 23°C. At this temperature, 15--20% of the cells exhibited such mitotic defects as large-budded cells with a single nucleus (*J*), mitosis occurring within the mother cell (*K*), and mother cells containing two nuclei (*L*).](JCB32925.f3){#F3}

###### 

Nuclear Positioning Defects in kar9 Mutants

                                A         B         C          D           
  ---- -- --------- -- ----- -- ------ -- ------ -- ------- -- -------- -- --------
  30      WT           309      0.0%      0.3%      1.3%        0.7%        2.3%
  30      *dhc1Δ*      241      0.0%      1.7%      2.5%        3.7%        7.9%
  30      *kar9Δ*      256      0.4%      4.3%      4.3%        3.9%          13%
  12      WT           402      0.0%      0.4%      1.7%        0.4%        2.1%
  12      *dhc1Δ*      201      1.0%      7.5%         4%       9.5%         22%
  12      *kar9Δ*      278      0.0%      2.9%         5%         13%         21%

The position of nuclear DNA was visualized by DAPI staining in asynchronously growing cultures of early exponential dhc1Δ (MS4262), kar9Δ (MS4589), and wildtype (MS52) strains at 308 and 128C. The percentage of abnormal nuclear position phenotypes are shown relative to the total cell culture. The remaining percents appeared wild type. *A*, anucleate cell. *B*, large-budded cell with a single nucleus in the mother cell. *C*, mitosis occurring within the mother cell. *D*, large-budded cell with two nuclei per mother cell. A representative experiment is shown. In repeat experiments, percentage vary by about 5%. *n*, the total cells counted. *Σ*, the sum of nuclear positioning defects.  

###### 

Quantitation of cytoplasmic microtubule orientation defect. The percentage of cells with cytoplasmic microtubule orientation defects was determined in *A* (cells carrying out anaphase within the mother cell), and *B* (cells with two nuclei within the mother cell by indirect immunofluorescence). The *kar9Δ* strain (MS4306), the *dhc1Δ* strain (MS4903), and the wild-type strain (MS1554), were grown to early exponential phase at 14°C, and then fixed for indirect immunofluorescence using the tubulin antibody, YOL1/34.

![](JCB32925.f4a)

![](JCB32925.f4b)

###### 

Viability of kar9Δ Double Mutants

               Viability with *kar9Δ*      Tetrads (PD:TT:NPDs)      Predicted double mutants                  Percent of double mutants dead or forming microcolonies
  --------- -- ------------------------ -- ---------------------- -- -------------------------------------- -- ---------------------------------------------------------
  *dhc1Δ*      not viable                  32 (2:25:5)                    35                                   100
  *jnm1Δ*      not viable                  17 (4:12:1)                    14                                   100
  *act5Δ*      not viable                  23 (7:12:4)                    20                                   100
                                                                                                               
  *bik1Δ*      not viable                  16 (3:10:3)                    16                                    94
                                                                                                               
  *smy1Δ*      viable                      8 (0:6:2)                      10                                     0
  *cin8Δ*      viable                       15 (2:8:5)                    18                                   33[\*](#TFV-150){ref-type="table-fn"}
  *kip1Δ*      viable                      7 (0:7:0)                       7                                     0
  *kar3Δ*      viable                      22 (6:13:3)               15[‡](#TFV-152){ref-type="table-fn"}      NA[§](#TFV-153){ref-type="table-fn"}

Double mutants were created by crosses. 2--3 d after germination, plates were scored for colony size and the presence of microcolonies. The following crosses were carried out to create the corresponding *kar9Δ* double mutants. *kar9Δ dhc1Δ* MS4262 × MS4589. *kar9Δ act5Δ* MS4586 × MS4263. *kar9Δ jnm1Δ* MS4321 × MS4587. *kar9Δ bik1Δ*, MS4734 × MS4313. *kar9Δsmy1Δ*, APY4ΔD5 × MS4062. *kar9Δ cin8Δ*, MAY2058 × MS4306. *kar9Δ kip1Δ*, MS2305 × MS4263. For the analysis of *kar9Δ kar3Δ* double mutants, MS1614, which carries *KAR3* on a *URA3*-marked *CEN* plasmid was crossed to the *KAR9* delete strain (MS4306). This yielded 15 double mutants carrying the *KAR3 URA3 CEN* plasmid. The ability of the double mutant to lose the *KAR3* plasmid and grow was assayed on plates containing 5-fluoro-orotic acid plates. The ability of the double mutant to lose the *KAR3* plasmid was not significantly different in comparison to that of the *kar3Δ* single mutants. *NA*, not applicable.  

 This is the same rate found for single *cin8Δ* mutants.  

 Plasmid loss assay on media containing 5-fluoro-orotic acid was used for the analysis of *KAR3*.  

 This represents the number of *kar9Δ kar3Δ* double mutants that carried the *KAR3 URA3* plasmid.  

![Synthetic lethality. *kar9-Δ1*::*LEU2* (MS4589) was crossed to *dhc1Δ::URA* (MS4262). Spores were allowed to germinate 4 d on YPD and photographed (*A*). Arrows show double-mutant microcolonies. 15--20 microcolonies were removed from the dissection plate, fixed, and then stained with DAPI. Examples of the *kar9Δ dhc1Δ* double mutant (*B*), and *kar9Δ bik1-518* double mutant (*C*) are shown using DAPI and Nomarski double-exposure images.](JCB32925.f5){#F5}

![Localization of GFP-Kar9p in shmoos and zygotes. *kar9Δ* shmoos (MS4382) (*A--C*), pre-zygotes (MS4671X MS4387) (*D--F*), and budding zygotes (MS4671X MS4387) (*G--I*), each expressing GFP-Kar9p (pMR3465) were fixed and stained with DAPI. In each instance, \>90% of all cells showed GFP localization. GFP: *A*, *D*, and *G.* DAPI: *B*, *E*, and *H.* Nomarski: *C*, *F*, and *I.*](JCB32925.f6){#F6}

![Cell cycle--dependent localization of GFP-Kar9p. The cell cycle position of a wild-type strain expressing GFP-Kar9p (MS4387) was estimated based on bud size and nuclear morphology. The GFP localization pattern was then determined in unbudded or G1 cells (*A--C*), small-budded to medium-budded cells or S to M phase cells (*D--F*), anaphase (*G--I*), and telophase (*J--L*) cells. A rare telophase cell with an abnormal localization pattern is shown in panel *M.* Minor localization patterns were found to be a subset of these six dots. The largest subsets of minor localization patterns were those of two and three dots. *GFP*: *A*, *D*, *G*, *J*, and *M.* DAPI: *B*, *E*, *H*, *K*, and *N.* Nomarski: *C*, *F*, *I*, *L*, and *O.*](JCB32925.f7){#F7}

![Quantification of GFP-Kar9p localization. The cell cycle position of cells expressing GFP-Kar9p was estimated as described in Fig. [7](#F7){ref-type="fig"}. Cells in the *Other* category had one or more dots in the locations depicted in Fig. [7](#F7){ref-type="fig"} *M.* Subsets of two or three dots were the most common minor localization patterns.](JCB32925.f8){#F8}

![Cytoplasmic microtubules intersect the GFP-Kar9p dot. Double-label indirect immunofluorescence was carried out on wild-type shmoos (*A--D*) and cells (*E--H*) expressing GFP-Kar9p using anti-GFP and anti-tubulin (YOL 1/34). Two shmoos are shown in *A--D* and three cells are shown in *E--H.* Anti-tubulin: *A* and *E.* GFP: *B* and *F.* DAPI: *C* and *G.* Nomarski: *D* and *H.*](JCB32925.f9){#F9}

###### 

Kar9p localization at the cortex is independent of microtubules. The wild-type strain (MS1556) containing the *GFP-KAR9* plasmid (pMR3465), was grown to early exponential phase. Representative examples of each phenotype scored are shown. 100 cells were counted for each analysis of GFP-Kar9p localization and anti-tubulin. Shmoos displaying both a dot and a line emanating from the dot were scored in the cortical dot category. Under conditions *A* and *B*, GFP-Kar9p expression was induced for 1.5 h. Microtubules were then depolymerized by the addition of nocodazole (see Materials and Methods) or mock treated with DMSO. Under conditions *C* and *D*, cells were treated simultaneously with α factor and nocodazole or DMSO for 1.5 h to create shmoos devoid of microtubules. GFP-Kar9p was then induced for an additional 1.75 h by the addition of galactose. Whereas this treatment also resulted in some cells with a large-budded arrest phenotype, only cells with a distinct shmoo morphology were counted in this analysis. Under conditions *E* and *F*, GFP-Kar9p expression was induced for 2 h. Microtubules were then depolymerized by nocodazole or mock treated with DMSO. Under conditions *G* and *H*, microtubules were depolymerized with nocodazole or mock treated with DMSO for 1.5 h. GFP-Kar9p expression was then induced by the addition of galactose. Because of the cell cycle constraints of GFP-Kar9p localization in cells, only large-budded cells not yet in anaphase were scored. Cells with two GFP-Kar9p dots in a line were scored in the cortical dot category if one of the dots was at the bud cortex. Cells with a cortical dot and a distinct line emanating from it were scored in the line category. *αF*, α factor.
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